Day One Biopharmaceuticals, Inc. (DAWN)

8.42 -0.09 (-1.06%) USD  |  NASDAQ  |  Dec 11, 16:00
8.51 +0.09 (+1.07%) Pre-Market: 08:02
More

Day One Biopharmaceuticals Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for DAWN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

View Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

View Research and Development Expense (% of Annual Revenues) Benchmarks
Start Trial
Mersana Therapeutics, Inc. Upgrade
Iovance Biotherapeutics, Inc. Upgrade
Lantheus Holdings, Inc. Upgrade
iRhythm Technologies, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade